Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Altamira Therapeutics Ltd
(NQ:
CYTO
)
1.560
UNCHANGED
Streaming Delayed Price
Updated: 3:51 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altamira Therapeutics Ltd
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Via
Benzinga
Why Is Fortinet (FTNT) Stock Down 22% Today?
November 03, 2023
Fortinet stock is dropping on Friday as investors in FTNT lament the company's revenue outlook included in its latest earnings report.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
Why Is Bill Holdings (BILL) Stock Down 29% Today?
November 03, 2023
Bill stock is falling on Friday as investors in the company react to its lackluster guidance in its fiscal Q1 2024 earnings report.
Via
InvestorPlace
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
November 03, 2023
Gainers Altamira Therapeutics Ltd (NASDAQ: CYTO) shares surged 54.1% to $0.25 in pre-market trading after gaining 5% on Thursday.
Via
Benzinga
Why Is Innovative International (IOAC) Stock Up 9% Today?
November 03, 2023
Innovative International stock is rising on Friday with heavy trading of IOAC shares following results from a shareholder meeting.
Via
InvestorPlace
Why Is Altamira Therapeutics (CYTO) Stock Up 28% Today?
November 03, 2023
Altamira Therapeutics stock is rising higher on Friday with heavy trading of CYTO shares despite a lack of news from the company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 03, 2023
It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!
Via
InvestorPlace
RNA Therapies Hold The Power To Transform Treatment For Numerous Ailments, But Delivering These Remains Problematic – Will This Biotech Change That?
September 19, 2023
Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access.
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
September 15, 2023
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 15, 2023
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
September 14, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
September 12, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Earnings Scheduled For September 12, 2023
September 12, 2023
Companies Reporting Before The Bell • Root (NASDAQ:ROOT) is projected to report quarterly loss at $0.10 per share on revenue of $48.95 million.
Via
Benzinga
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
September 06, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
August 23, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia
July 20, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journal
July 17, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Why Altamira Therapeutics (CYTO) Stock Is Getting Hammered
July 06, 2023
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 19.23% to $0.44 Thursday morning after the company announced pricing of a $5 million public offer
Via
Benzinga
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
July 06, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 06, 2023
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
July 05, 2023
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome
June 15, 2023
Via
ACCESSWIRE
Altamira Therapeutics Announces Publication of Peer-Reviewed Article on Peptide-Based RNA Delivery for Extrahepatic Targets
May 31, 2023
Via
ACCESSWIRE
Altamira Therapeutics Reports Positive Top-Line Data from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
May 24, 2023
Via
ACCESSWIRE
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
May 16, 2023
Via
ACCESSWIRE
Altamira Therapeutics to Host Fiscal Year 2022 Financial Results and Business Update Call on May 16th 2023
May 12, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.